Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishishinbashi, Minato-ku, Tokyo, 105-8461, Japan.
Surg Endosc. 2021 Dec;35(12):6513-6523. doi: 10.1007/s00464-020-08148-5. Epub 2020 Nov 13.
Laparoscopic Heller-myotomy with Dor-fundoplication (LHD) is the standard surgical treatment for achalasia; however, surgical outcomes over a period greater than 10 years have not been well-explored. The objective of this study was to evaluate the long-term outcomes of LHD for achalasia based on a single-center experience.
Patients who underwent LHD between 1994 and 2019 were included. Of these, we excluded patients who had undergone foregut surgery or whose follow-up data were unavailable. Esophagogastroduodenoscopy (EGD) findings and postoperative persistent and/or recurrent symptoms had been assessed annually. Disease-free rates were calculated using Kaplan-Meier analysis.
A total of 530 patients (mean age 45.0 years with 267 men) were included. The median follow-up period was 50.5 months. More than 10 years' data were available in 78 patients (14.7%). The cumulative rates of freedom from dysphagia, vomiting, chest pain, and Eckardt score > 3 at 10 years after LHD were 80.1%, 97.5%, 96.3%, and 73.5%, respectively. Probability of esophagitis during 10 years after surgery was 34.4% of patients based on Kaplan-Meier estimation. Approximately 3/4 of patients who had post-LHD esophagitis showed mild esophagitis of Los Angeles classification grade A. Fifteen patients (2.8%) were required a revision of primary LHD. Six patients (1.2%) developed esophageal cancer with an incidence was as high as 219.8/100,000 person-year. All patients with esophageal cancer were found to have early stage tumors that were successfully resected.
Symptomatic relief post-LHD lasted for over 10 years. The incidence rate of esophageal cancer was high. Regular EGD surveillance seems to be helpful for early detection of esophageal cancer early.
腹腔镜 Heller 肌切开术加 Dor 胃底折叠术(LHD)是贲门失弛缓症的标准手术治疗方法;然而,超过 10 年的手术结果尚未得到很好的探索。本研究的目的是基于单中心经验评估 LHD 治疗贲门失弛缓症的长期结果。
纳入 1994 年至 2019 年期间行 LHD 的患者。排除行上消化道手术或随访资料缺失的患者。每年评估食管胃十二指肠镜(EGD)检查结果和术后持续性和/或复发性症状。使用 Kaplan-Meier 分析计算无疾病生存率。
共纳入 530 例患者(平均年龄 45.0 岁,男性 267 例)。中位随访时间为 50.5 个月。78 例(14.7%)患者有超过 10 年的数据。LHD 后 10 年无吞咽困难、呕吐、胸痛和 Eckardt 评分>3 的累积缓解率分别为 80.1%、97.5%、96.3%和 73.5%。根据 Kaplan-Meier 估计,术后 10 年内食管炎的概率为 34.4%。约 3/4 的 LHD 术后食管炎患者表现为洛杉矶分类 A 级轻度食管炎。15 例(2.8%)患者需要对原发性 LHD 进行修正。6 例(1.2%)患者发生食管癌,发病率高达 219.8/100000 人年。所有食管癌患者均发现为早期肿瘤,成功切除。
LHD 后症状缓解持续 10 年以上。食管癌的发病率较高。定期 EGD 监测似乎有助于早期发现食管癌。